AskVantage

Pairidex

Pairidex is a startup headquartered in St. Louis, United States, founded in 2023. It has raised at least $1.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2023Founded
StartupStage
St. Louis, United StatesHeadquarters
BiotechnologyIndustry
$1.1m+Raised (SEC filings)
SeedFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

Pairidex has raised at least $1.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

Other startups in St. Louis

Related

Questions and answers

What does Pairidex do?

Pairidex is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has Pairidex raised?

At least $1.1m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Pairidex based?

Pairidex is headquartered in St. Louis, United States.

When was Pairidex founded?

Pairidex was founded in 2023.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.